We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRPT icon
126
Freshpet
FRPT
$2.93B
$32.7M 0.25%
390,522
-118,753
-23% -$8.94M
SIRI icon
127
SiriusXM
SIRI
$9.98B
$32.6M 0.25%
556,090
-561,673
-50% -$31.5M
RGEN icon
128
Repligen
RGEN
$7.96B
$32.3M 0.25%
261,448
-79,297
-23% -$9.33M
JBTM
129
JBT Marel
JBTM
$7.21B
$32M 0.25%
372,175
-256,232
-41% -$19.9M
GO icon
130
Grocery Outlet
GO
$909M
$32M 0.25%
783,367
– –
BPMC
131
DELISTED
Blueprint Medicines
BPMC
$31.7M 0.24%
406,773
– –
ZNGA
132
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$31.3M 0.24%
3,285,875
-173,325
-5% -$1.42M
GGG icon
133
Graco
GGG
$12.9B
$30.9M 0.24%
644,255
-303,094
-32% -$14.3M
SLAB icon
134
Silicon Laboratories
SLAB
$7.17B
$30.8M 0.24%
306,961
– –
P
135
Everpure Inc
P
$25.7B
$30.6M 0.24%
1,764,225
+234,625
+15% +$3.52M
ORLY icon
136
O'Reilly Automotive
ORLY
$72.9B
$30.5M 0.24%
1,086,585
+960,960
+765% +$25.1M
ALNY icon
137
Alnylam Pharmaceuticals
ALNY
$27.5B
$29.9M 0.23%
+201,572
New +$27.2M
SIVB
138
DELISTED
SVB Financial Group
SIVB
$29.7M 0.23%
137,969
+10,594
+8% +$2.04M
ALLY icon
139
Ally Financial
ALLY
$13.2B
$29.7M 0.23%
1,499,400
+358,400
+31% +$6.1M
MPC icon
140
Marathon Petroleum
MPC
$92.4B
$29.2M 0.23%
+782,325
New +$25.1M
PEN icon
141
Penumbra
PEN
$12.7B
$29.2M 0.23%
163,485
-16,450
-9% -$2.85M
PFPT
142
DELISTED
Proofpoint, Inc.
PFPT
$29.2M 0.23%
262,972
– –
NUVA
143
DELISTED
NuVasive, Inc.
NUVA
$28.8M 0.22%
517,482
+132,025
+34% +$7.64M
OC icon
144
Owens Corning
OC
$11.2B
$28.6M 0.22%
513,075
-53,375
-9% -$2.49M
BKR icon
145
Baker Hughes
BKR
$60B
$28.6M 0.22%
1,855,932
-2,240,669
-55% -$32.8M
DRNA
146
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$28.5M 0.22%
1,120,359
– –
FOLD
147
DELISTED
Amicus Therapeutics
FOLD
$28M 0.22%
1,859,320
– –
TXN icon
148
Texas Instruments
TXN
$252B
$28M 0.22%
220,479
-9,985
-4% -$1.16M
FCFS icon
149
FirstCash
FCFS
$8.85B
$27.8M 0.21%
411,294
– –
PG icon
150
Procter & Gamble
PG
$336B
$27.6M 0.21%
231,019
-49,051
-18% -$5.72M
4 5
6
7 8

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.